Veterinary Medicines

Trilotab 150 mg chewable tablets for dogs

Authorised
  • Trilostane
Download as PDF

Product identification

Medicine name:
Trilotab 150 mg chewable tablets for dogs
Trilotab vet, 150 mg, kramtomosios tabletės šunims
Active substance:
  • Trilostane
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Trilostane
    150.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH02CA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:
  • Aluminium-PVC/Aluminium/oPA blisters, containing 10 tablets. Cardboard box of 10 blisters of 10 tablets
  • Aluminium-PVC/Aluminium/oPA blisters, containing 10 tablets. Cardboard box of 3 blister of 10 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • CP-Pharma Handelsgesellschaft mbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • CP-Pharma Handelsgesellschaft mbH
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/23/2774/001-002
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0373/005
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Poland
  • Portugal
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Lithuanian (PDF)
Published on: 9/09/2024
Updated on: 19/09/2024
Download